Ajanta Pharma shares zoom 14% on stellar Q4 earnings, buyback plans

Ajanta Pharma approved its fourth buyback plan in as many years, offering a premium of 25 percent to stakeholders.

Related Keywords

Ajanta Pharma , ,Institutional Equities ,Uzzing Stocks ,Uyback ,Ajanta Pharma Buyback ,Ajanta Pharma Q4 ,Janta Pharma Q4 Earnings ,Ajanta Pharma Q4 Results ,Ajanta Pharma Share ,Ajanta Pharma Share Price ,Ajanta Pharma Stock Price ,